{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T05:25:41Z","timestamp":1794029141580,"version":"4.8.0"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,2]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE:<\/jats:title>\n                    <jats:p>The endocannabinoid system is involved in pain perception and inflammation. Cannabis contains delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), which are cannabinoids that bind to endocannabinoid system receptors. A fatty acid amide called palmitoylethanolamide (PEA) enhances endogenous cannabinoids. Given that use of medical cannabis is increasing, we sought to characterize patterns of cannabis use for gynecologic pain and its effectiveness as an analgesic.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>DATA SOURCES:<\/jats:title>\n                    <jats:p>We searched PubMed, EMBASE, Scopus, Cochrane, and ClinicalTrials.gov using terms for \u201cwoman,\u201d \u201ccannabis,\u201d and \u201cpain\u201d or \u201cpelvic pain\u201d or \u201cendometriosis\u201d or \u201cbladder pain\u201d or \u201ccancer.\u201d The search was restricted to English-language articles published between January 1990 and April 2021 and excluded animal studies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS OF STUDY SELECTION:<\/jats:title>\n                    <jats:p>The initial search yielded 5,189 articles with 3,822 unique citations. Studies were included if they evaluated nonpregnant adult women who used cannabinoids for gynecologic pain conditions (eg, chronic pelvic pain, vulvodynia, endometriosis, interstitial cystitis, malignancy). Study types included were randomized controlled trials (RCTs), cohort studies, and cross-sectional studies. Covidence systematic review software was used.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>TABULATION, INTEGRATION, AND RESULTS:<\/jats:title>\n                    <jats:p>Fifty-nine studies were considered for full review, and 16 met inclusion criteria. Prevalence of cannabis use ranged from 13% to 27%. Most women ingested or inhaled cannabis and used cannabis multiple times per week, with dosages of THC and CBD up to 70 mg and 2,000 mg, respectively. Sixty-one to 95.5% reported pain relief. All six prospective cohort studies and one RCT of PEA-combination medications reported significant pain relief, and the average decrease in pain after 3 months of treatment was 3.35\u00b11.39 on the 10-point visual analog scale. However, one fatty acid amide enzyme inhibitor RCT did not show pain reduction.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION:<\/jats:title>\n                    <jats:p>Survey data showed that most women reported that cannabis improved pain from numerous gynecologic conditions. Cohort studies and an RCT using PEA-combination medications reported pain reduction. However, interpretation of the studies is limited due to varying cannabis formulations, delivery methods, and dosages that preclude a definitive statement about cannabis for gynecologic pain relief.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>SYSTEMATIC REVIEW REGISTRATION:<\/jats:title>\n                    <jats:p>PROSPERO, CRD42021248057.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/aog.0000000000004656","type":"journal-article","created":{"date-parts":[[2022,1,6]],"date-time":"2022-01-06T17:10:51Z","timestamp":1641489051000},"page":"287-296","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":50,"title":["Medical Cannabis for Gynecologic Pain Conditions"],"prefix":"10.1097","volume":"139","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7415-3112","authenticated-orcid":false,"given":"Angela L.","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin L.","family":"Gingher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenell S.","family":"Coleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,1,5]]},"reference":[{"key":"R1-20261107","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1001\/jama.2021.2631","article-title":"Chronic pelvic pain in women: a review","volume":"325","author":"Lamvu","year":"2021","journal-title":"JAMA"},{"key":"R2-20261107","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.fertnstert.2011.05.090","article-title":"Impact of endometriosis on quality of life and work productivity: a multicenter study across ten countries","volume":"96","author":"Nnoaham","year":"2011","journal-title":"Fertil Steril"},{"key":"R3-20261107","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1038\/nn1992","article-title":"The neuropathic pain triad: neurons, immune cells and glia","volume":"10","author":"Scholz","year":"2007","journal-title":"Nat Neurosci"},{"key":"R4-20261107","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1016\/j.cell.2021.04.041","article-title":"Endometriosis: etiology, pathobiology, and therapeutic prospects","volume":"184","author":"Saunders","year":"2021","journal-title":"Cell"},{"key":"R5-20261107","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s13311-015-0380-8","article-title":"Safety and toxicology of cannabinoids","volume":"12","author":"Sachs","year":"2015","journal-title":"Neurotherapeutics"},{"key":"R6-20261107","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ygyno.2019.12.013","article-title":"Use of cannabinoids in cancer patients: a Society of Gynecologic Oncology (SGO) clinical practice statement","volume":"157","author":"Whitcomb","year":"2020","journal-title":"Gynecol Oncol"},{"key":"R7-20261107","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1071\/CH21006","article-title":"The chemistry of cannabis and cannabinoids","volume":"74","author":"Duggan","year":"2021","journal-title":"Aust J Chem"},{"key":"R8-20261107","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/365061a0","article-title":"Molecular characterization of a peripheral receptor for cannabinoids","volume":"365","author":"Munro","year":"1993","journal-title":"Nature"},{"key":"R9-20261107","doi-asserted-by":"crossref","first-page":"9828397","DOI":"10.1155\/2019\/9828397","article-title":"Micronized palmitoylethanolamide-polydatin reduces the painful symptomatology in patients with interstitial cystitis\/bladder pain syndrome","volume":"2019","author":"Cervigni","year":"2019","journal-title":"Biomed Res Int"},{"key":"R10-20261107","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1007\/s00345-020-03372-z","article-title":"An adaptive randomized clinical trial in interstitial cystitis\/bladder pain syndrome evaluating efficacy of ASP3652 and the relationship between disease characteristics and Hunner's lesions","volume":"39","author":"Houbiers","year":"2021","journal-title":"World J Urol"},{"key":"R11-20261107","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.neuropharm.2008.04.018","article-title":"Inhibition of fatty acid amide hydrolase and cyclooxygenase-2 increases levels of endocannabinoid related molecules and produces analgesia via peroxisome proliferator-activated receptor-alpha in a model of inflammatory pain","volume":"55","author":"Jhaveri","year":"2008","journal-title":"Neuropharmacology"},{"key":"R12-20261107","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S0015-0282(02)02959-X","article-title":"Oxidative stress and peritoneal endometriosis","volume":"77","author":"Van Langendonckt","year":"2002","journal-title":"Fertil Steril"},{"key":"R19-20261107","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1080\/00952990.2019.1569668","article-title":"Time trends in US cannabis use and cannabis use disorders overall and by sociodemographic subgroups: a narrative review and new findings","volume":"45","author":"Hasin","year":"2019","journal-title":"Am J Drug Alcohol Abuse"},{"key":"R20-20261107","doi-asserted-by":"crossref","first-page":"e1911936","DOI":"10.1001\/jamanetworkopen.2019.11936","article-title":"A national survey of marijuana use among US adults with medical conditions, 2016-2017","volume":"2","author":"Dai","year":"2019","journal-title":"JAMA Netw Open"},{"key":"R21-20261107","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1001\/virtualmentor.2014.16.09.hlaw1-1409","article-title":"Physicians, medical marijuana, and the law","volume":"16","author":"Gregorio","year":"2014","journal-title":"Virtual Mentor"},{"key":"R22-20261107","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/AOG.0000000000004207","article-title":"Recreational cannabis use before and after legalization in women with pelvic pain","volume":"137","author":"Geoffrion","year":"2021","journal-title":"Obstet Gynecol"},{"key":"R23-20261107","doi-asserted-by":"crossref","first-page":"100497","DOI":"10.1016\/j.gore.2019.100497","article-title":"Non-prescription cannabis use for symptom management amongst women with gynecologic malignancies","volume":"30","author":"Blake","year":"2019","journal-title":"Gynecol Oncol Rep"},{"key":"R24-20261107","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1089\/jwh.2020.8737","article-title":"Use of cannabis for self-management of chronic pelvic pain","volume":"30","author":"Carrubba","year":"2021","journal-title":"J Womens Health (Larchmt)"},{"key":"R25-20261107","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12906-019-2431-x","article-title":"Self-management strategies amongst Australian women with endometriosis: a national online survey","volume":"19","author":"Armour","year":"2019","journal-title":"BMC Complement Altern Med"},{"key":"R26-20261107","doi-asserted-by":"crossref","first-page":"100667","DOI":"10.1016\/j.gore.2020.100667","article-title":"Prescribed medical cannabis in women with gynecologic malignancies: a single-institution survey-based study","volume":"34","author":"Webster","year":"2020","journal-title":"Gynecol Oncol Rep"},{"key":"R27-20261107","doi-asserted-by":"crossref","first-page":"139","DOI":"10.26828\/cannabis.2020.02.001","article-title":"Cannabis and vulvodynia symptoms: a preliminary report","volume":"3","author":"Barach","year":"2020","journal-title":"Cannabis"},{"key":"R28-20261107","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1089\/jwh.2020.8668","article-title":"Illicit cannabis usage as a management strategy in New Zealand women with endometriosis: an online survey","volume":"30","author":"Armour","year":"2021","journal-title":"J Womens Health (Larchmt)"},{"key":"R29-20261107","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jogc.2019.08.033","article-title":"Cannabis use, a self-management strategy among Australian women with endometriosis: results from a national online survey","volume":"42","author":"Sinclair","year":"2020","journal-title":"J Obstet Gynaecol Can"},{"key":"R30-20261107","first-page":"413","article-title":"Chronic pelvic pain, quality of life and sexual health of women treated with palmitoylethanolamide and \u03b1-lipoic acid","volume":"67","author":"Caruso","year":"2015","journal-title":"Minerva Ginecol"},{"key":"R31-20261107","doi-asserted-by":"crossref","first-page":"191","DOI":"10.23736\/S0026-4784.19.04384-3","article-title":"Role of a natural integrator based on lipoic acid, palmitoiletanolamide and myrrh in the treatment of chronic pelvic pain and endometriosis","volume":"71","author":"De Leo","year":"2019","journal-title":"Minerva Ginecol"},{"key":"R32-20261107","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ejogrb.2010.01.008","article-title":"Effect of palmitoylethanolamide-polydatin combination on chronic pelvic pain associated with endometriosis: preliminary observations","volume":"150","author":"Indraccolo","year":"2010","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R33-20261107","doi-asserted-by":"crossref","first-page":"443","DOI":"10.2147\/IJWH.S204275","article-title":"Effect of ultramicronized-palmitoylethanolamide and co-micronizedpalmitoylethanolamide\/polydatin on chronic pelvic pain and quality of life in endometriosis patients: an open-label pilot study","volume":"11","author":"Loi","year":"2019","journal-title":"Int J Womens Health"},{"key":"R34-20261107","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ejogrb.2013.01.009","article-title":"The adjuvant use of N-palmitoylethanolamine and transpolydatin in the treatment of endometriotic pain","volume":"168","author":"Giugliano","year":"2013","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R35-20261107","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.jpag.2014.12.011","article-title":"Effectiveness of the association N-palmitoylethanolamine and transpolydatin in the treatment of primary dysmenorrhea","volume":"28","author":"Tartaglia","year":"2015","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"R36-20261107","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.2147\/JPR.S278718","article-title":"Cannabidiol as a treatment for chronic pain: a survey of patients' perspectives and attitudes","volume":"14","author":"Schilling","year":"2021","journal-title":"J Pain Res"},{"key":"R37-20261107","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.pmn.2020.11.006","article-title":"Cannabis for chronic pain: a rapid systematic review of randomized control trials","volume":"22","author":"Longo","year":"2021","journal-title":"Pain Manag Nurs"},{"key":"R38-20261107","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s10787-019-00582-9","article-title":"A double-blind randomized placebo controlled study assessing safety, tolerability and efficacy of palmitoylethanolamide for symptoms of knee osteoarthritis","volume":"27","author":"Steels","year":"2019","journal-title":"Inflammopharmacology"},{"key":"R39-20261107","first-page":"99","article-title":"Palmitoylethanolamide versus a nonsteroidal anti-inflammatory drug in the treatment of temporomandibular joint inflammatory pain","volume":"26","author":"Marini","year":"2012","journal-title":"J Orofac Pain"},{"key":"R40-20261107","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1111\/apt.13958","article-title":"Randomised clinical trial: the analgesic properties of dietary supplementation with palmitoylethanolamide and polydatin in irritable bowel syndrome","volume":"45","author":"Cremon","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"R41-20261107","doi-asserted-by":"crossref","first-page":"9371","DOI":"10.1073\/pnas.161191698","article-title":"Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase","volume":"98","author":"Cravatt","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R42-20261107","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1016\/j.pain.2012.04.020","article-title":"An efficient randomised, placebo-controlled clinical trial with the irreversible fatty acid amide hydrolase-1 inhibitor PF-04457845, which modulates endocannabinoids but fails to induce effective analgesia in patients with pain due to osteoarthritis of the knee","volume":"153","author":"Huggins","year":"2012","journal-title":"Pain"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000004656","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T05:00:49Z","timestamp":1794027649000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000004656"}},"subtitle":["A Systematic Review"],"short-title":[],"issued":{"date-parts":[[2022,1,5]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000004656","relation":{},"ISSN":["0029-7844","1873-233X"],"issn-type":[{"value":"0029-7844","type":"print"},{"value":"1873-233X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,5]]},"assertion":[{"value":"2021-09-14","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-11-10","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}